Structure

InChI Key UZHSEJADLWPNLE-GRGSLBFTSA-N
Smiles C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5
InChI
InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H21NO4
Molecular Weight 327.38
AlogP 1.3
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 2.0
Polar Surface Area 70.0
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 24.0
Assay Description Organism Bioactivity Reference
Narcotic antagonistic potency evaluated in morphine-induced Straub tail phenomenon in mice Mus musculus 2.951 nM
In vivo binding affinity against mu opioid receptor was measured by using labeled ligand [3H]naloxone (0.5 nM) Cavia porcellus 1.1 nM
Displacement of 0.5 nM [3H]bremazocine from guinea pig brain membrane opioid receptor kappa with 100 nM DAGO and 100 nM DPDPE Cavia porcellus 50.0 nM
Inhibition of opioid receptor kappa by displacing 0.5 nM [3H]bremazocine in guinea pig brain membrane Cavia porcellus 50.0 nM
Inhibition of [3H]U-69593 binding to human Opioid receptor kappa 1 expressed in HEK 293 cells Homo sapiens 1.2 nM
Negative logarithm of the molar concentration of Opioid receptor mu 1 was determined in guinea pig ileum Cavia porcellus 1.862 nM
Inhibition of [3H]naltrindole binding to human Opioid receptor delta 1 in CHO cells Homo sapiens 41.0 nM
Concentration required to inhibit the binding of the non-selective opioid antagonist, [3H]diprenorphine, to cloned human delta opioid receptor Homo sapiens 33.0 nM
Inhibition of total opioid receptor by displacing 0.5 nM [3H]bremazocine in guinea pig brain membrane Cavia porcellus 43.0 nM
Inhibition of 0.5 nM [3H]bremazocine binding to guinea pig brain membrane opioid receptors Cavia porcellus 43.0 nM
Displacement of [3H]bremazocine from opioid receptor of guinea pig membrane Cavia porcellus 23.0 nM
Affinity to opioid receptor kappa 1 using [3H]U-69593 as radioligand in homogenates of guinea pig brain membranes Cavia porcellus 3.2 nM
inhibition of 1.0 nM [3H]- DAGO binding to guinea pig brain membrane opioid receptor mu Cavia porcellus 8.9 nM
Inhibition of opioid receptor mu by displacing 1 nM [3H]DAGO in guinea pig brain membrane Cavia porcellus 8.9 nM
Inhibition of [3H]naloxone receptor binding to opioid receptor in the absence of 100 mM NaCl Rattus norvegicus 3.2
Inhibition of [3H]naloxone receptor binding to opioid receptor in the presence of 100 mM NaCl Rattus norvegicus 3.0
Compound was evaluated for opioid receptor affinity against the receptor site model site 5 Rattus norvegicus 154.0 nM
In vivo binding affinity against kappa opioid receptor was measured by using labeled ligand [3H]ethylketocyclazocine (1 nM) with 500 nM DADLE and 20 nM sufentanil Cavia porcellus 12.0 nM
Inhibition of 0.5 nM [3H]- Bremazocine binding to Opioid receptor mu 1 of bovine striatum membrane Bos taurus 5.0 nM
Affinity against the Opioid receptor delta 1 Rattus norvegicus 18.0 nM

Related Entries

Cross References

Resources Reference
ChEBI 7459
ChEMBL CHEMBL80
DrugBank DB01183
DrugCentral 1878
FDA SRS 36B82AMQ7N
Human Metabolome Database HMDB0015314
Guide to Pharmacology 1676
KEGG C07252
PharmGKB PA450586
PubChem 5284596
SureChEMBL SCHEMBL34284
ZINC ZINC000000389747